Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma
Clinical trial NCT03710876 · COMPLETED
Trial details
- NCT number
- NCT03710876
- Sponsor
- Ferring Ventures Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2024-03-29
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.